M E Castellanos1, S Kirimunda1, L Martinez2, T Quach3, H Woldu3, R Kakaire1, A Handel3, S Zalwango4, N Kiwanuka4, C C Whalen1. 1. Global Health Institute, Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia. 2. Global Health Institute, Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia, School of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA. 3. Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia. 4. College of Health Sciences, School of Public Health, Makerere University, Kampala, Uganda.
Abstract
OBJECTIVE: To investigate diagnostic agreement of the QuantiFERON®-TB Gold In-Tube (QFT-GIT) test in adult tuberculin skin test (TST) converters in a high tuberculosis (TB) burden setting. SETTING AND DESIGN: We performed a case-cohort study from 2014 to 2016 in Uganda among residents who were not infected with Mycobacterium tuberculosis. Participants were followed up for 1 year, when they were retested to determine TST conversion. All TST converters and a random sample of participants from baseline were offered QFT-GIT testing. RESULTS: Of 368 enrolled participants, 61 (17%) converted their TST by 1 year. Among 61 converters, 42 were tested using QFT-GIT, 64% of whom were QFT-GIT-positive. Of 307 participants with a persistent negative TST, 48 were tested using QFT-GIT, 83% of whom were QFT-negative. Overall concordance of TST and QFT-GIT was moderate (κ = 0.48, 95%CI 0.30-0.66). Converters with a conversion of 15 mm had a higher proportion of concordant QFT-GIT results (79%) than converters with increments of 10-14.9 mm (52%). CONCLUSION: Concordance between TST and QFT-GIT was moderate among TST converters in this urban African population. These findings call for improved tests that more accurately measure conversion to tuberculous infection.
OBJECTIVE: To investigate diagnostic agreement of the QuantiFERON®-TB Gold In-Tube (QFT-GIT) test in adult tuberculin skin test (TST) converters in a high tuberculosis (TB) burden setting. SETTING AND DESIGN: We performed a case-cohort study from 2014 to 2016 in Uganda among residents who were not infected with Mycobacterium tuberculosis. Participants were followed up for 1 year, when they were retested to determine TST conversion. All TST converters and a random sample of participants from baseline were offered QFT-GIT testing. RESULTS: Of 368 enrolled participants, 61 (17%) converted their TST by 1 year. Among 61 converters, 42 were tested using QFT-GIT, 64% of whom were QFT-GIT-positive. Of 307 participants with a persistent negative TST, 48 were tested using QFT-GIT, 83% of whom were QFT-negative. Overall concordance of TST and QFT-GIT was moderate (κ = 0.48, 95%CI 0.30-0.66). Converters with a conversion of 15 mm had a higher proportion of concordant QFT-GIT results (79%) than converters with increments of 10-14.9 mm (52%). CONCLUSION: Concordance between TST and QFT-GIT was moderate among TST converters in this urban African population. These findings call for improved tests that more accurately measure conversion to tuberculous infection.
Authors: Morten Ruhwald; Henrik Aggerbeck; Rafael Vázquez Gallardo; Søren T Hoff; José I Villate; Bettine Borregaard; José A Martinez; Ingrid Kromann; Antón Penas; Luis L Anibarro; Maria Luiza de Souza-Galvão; Francisca Sánchez; Jose Ángel Rodrigo-Pendás; Antoni Noguera-Julian; Xavier Martínez-Lacasa; Maria Victoria Tuñez; Virginia Leiro Fernández; Joan P Millet; Antonio Moreno; Nazaret Cobos; José M Miró; Llanos Roldan; Angels Orcau; Peter Andersen; Joan A Caylá Journal: Lancet Respir Med Date: 2017-02-01 Impact factor: 30.700
Authors: Juliet N Sekandi; Sarah Zalwango; Allan K Nkwata; Leonardo Martinez; Robert Kakaire; Jane N Mutanga; Christopher C Whalen; Noah Kiwanuka Journal: Am J Trop Med Hyg Date: 2018-01-04 Impact factor: 2.345
Authors: Neus Altet; José Dominguez; Maria-Luiza de Souza-Galvão; M Ángeles Jiménez-Fuentes; Célia Milà; Jordi Solsona; Antonio Soriano-Arandés; Irene Latorre; Elisa Lara; Adela Cantos; María Dolores Ferrer; Àngels Orcau; Juan Ruiz-Manzano; Joan Caylà Journal: Ann Am Thorac Soc Date: 2015-05
Authors: Richard Long; Leyla Asadi; Courtney Heffernan; James Barrie; Christopher Winter; Mary Lou Egedahl; Catherine Paulsen; Brenden Kunimoto; Dick Menzies Journal: PLoS One Date: 2019-03-08 Impact factor: 3.240
Authors: Eva L Sudbury; Larissa Otero; Marc Tebruegge; Nicole L Messina; Carlos Seas; Martin Montes; Julia Rìos; Susie Germano; Kaya Gardiner; Vanessa Clifford; Eduardo Gotuzzo; Nigel Curtis Journal: J Clin Tuberc Other Mycobact Dis Date: 2019-04-25
Authors: Henok G Woldu; Sarah Zalwango; Leonardo Martinez; María Eugenia Castellanos; Robert Kakaire; Juliet N Sekandi; Noah Kiwanuka; Christopher C Whalen Journal: PLoS One Date: 2021-01-22 Impact factor: 3.240
Authors: Carlos Acuña-Villaorduña; Luiz Guilherme Schmidt-Castellani; Patricia Marques-Rodrigues; Laura F White; David Jamil Hadad; Mary Gaeddert; Jerrold J Ellner; Kevin P Fennelly; Moises Palaci; Reynaldo Dietze; Edward C Jones-López Journal: PLoS One Date: 2018-10-29 Impact factor: 3.240